North Growth Management’s Bristol-Myers Squibb BMY Stock Holding History

North Growth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-195,000	Closed	-$11.3M	–	49
2023 Q3	$11.3M	Sell	195,000 -25,000	-11%	-$1.53M	2.5%	13
2023 Q2	$14.1M	Hold	220,000	–	–	2.89%	11
2023 Q1	$15.2M	Sell	220,000 -3,000	-1%	-$212K	3.25%	8
2022 Q4	$16.1M	Sell	223,000 -32,000	-13%	-$2.41M	3.65%	7
2022 Q3	$18.1M	Hold	255,000	–	–	4.52%	3
2022 Q2	$19.6M	Hold	255,000	–	–	4.55%	3
2022 Q1	$18.6M	Buy	255,000 +2,000	+0.8%	+$134K	3.43%	8
2021 Q4	$15.8M	Hold	253,000	–	–	2.62%	13
2021 Q3	$15M	Hold	253,000	–	–	2.64%	12
2021 Q2	$16.9M	Buy	253,000 +20,000	+9%	+$1.3M	2.74%	9
2021 Q1	$14.7M	Buy	233,000 +23,000	+11%	+$1.43M	2.6%	11
2020 Q4	$13M	Sell	210,000 -16,000	-7%	-$984K	2.67%	10
2020 Q3	$13.6M	Buy	226,000 +20,000	+10%	+$1.2M	3%	10
2020 Q2	$12.1M	Buy	206,000 +20,000	+11%	+$1.2M	2.91%	9
2020 Q1	$10.4M	Buy	186,000 +38,000	+26%	+$2.32M	2.92%	11
2019 Q4	$9.53M	Hold	148,000	–	–	2.14%	23
2019 Q3	$7.53M	Buy	148,000 +46,000	+45%	+$2.16M	1.82%	29
2019 Q2	$4.63M	Buy	+102,000	New	+$4.75M	1.15%	40

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

North Growth Management's BMY Position: Q4 2023 in Review

North Growth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 195,000 shares — an estimated $11.3M sold.

North Growth Management first reported a position in BMY in Q2 2019 and held it in 18 quarters. The position peaked at $19.6M in Q2 2022. 2,364 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

North Growth Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
North Growth Management sold 195,000 Bristol-Myers Squibb shares in Q4 2023, an estimated $11.3M.
North Growth Management first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 18 quarters.
North Growth Management's Bristol-Myers Squibb position peaked at $19.6M in Q2 2022.
2,364 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on North Growth Management's 13F filing for Q4 2023, filed 7 Feb 2024.